Search research articles
Contact Us
Filters
Showing results (321-330 of 367) with videos related to
Page
of 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
M L Tetef, T W Synold, W Chow, et al.
Journal of Applied Microbiology
|
February 1, 2011
An international trial of quantitative PCR for monitoring Legionella in artificial water systems
J V Lee, S Lai, M Exner, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 16, 2021
Sinus rhythm heart rate increase after atrial fibrillation ablation is associated with lower risk of arrhythmia recurrence
Ammar M Killu, Chance M Witt, Alan M Sugrue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
M D Berger, S Stintzing, V Heinemann, et al.
Cancer Chemotherapy and Pharmacology
|
January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
Edward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
W Zhang, T Winder, Y Ning, et al.
British Journal of Pharmacology
|
October 16, 2007
Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase
R Kast, H Schirok, S Figueroa-Pérez, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 367) with videos related to
Sort By:
Page
of 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
M L Tetef, T W Synold, W Chow, et al.
Journal of Applied Microbiology
|
February 1, 2011
An international trial of quantitative PCR for monitoring Legionella in artificial water systems
J V Lee, S Lai, M Exner, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 16, 2021
Sinus rhythm heart rate increase after atrial fibrillation ablation is associated with lower risk of arrhythmia recurrence
Ammar M Killu, Chance M Witt, Alan M Sugrue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
M D Berger, S Stintzing, V Heinemann, et al.
Cancer Chemotherapy and Pharmacology
|
January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
Edward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
W Zhang, T Winder, Y Ning, et al.
British Journal of Pharmacology
|
October 16, 2007
Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase
R Kast, H Schirok, S Figueroa-Pérez, et al.
Page
of 37